Doctors track Real-World use of kidney drug in korea
NCT ID NCT07232537
Summary
This study aims to understand how the kidney-protecting drug finerenone is actually used by doctors and patients in South Korea. Researchers will observe and collect information from about 500 adults with chronic kidney disease and type 2 diabetes who are starting this already-approved medication as part of their regular care. The goal is to learn about treatment patterns, patient characteristics, and safety in a real-world setting over about one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many Locations
RECRUITINGMultiple Locations, South Korea
Conditions
Explore the condition pages connected to this study.